Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Halozyme Therapeutic (HALO)

Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ACT
1 Surging Stock for Long-Term Investors and 2 We Brush Off StockStory - Tue Jun 30, 11:36PM CDT

1 Surging Stock for Long-Term Investors and 2 We Brush Off

ACT : 45.34 (-0.11%)
HALO : 79.45 (+3.17%)
CLMT : 36.42 (-0.03%)
UPST
2 Profitable Stocks Worth Your Attention and 1 We Question StockStory - Wed Jun 17, 11:39PM CDT

2 Profitable Stocks Worth Your Attention and 1 We Question

ADM : 76.79 (+0.23%)
UPST : 34.78 (-2.69%)
HALO : 79.45 (+3.17%)
Halozyme Confirms It Projects Zero to Minimal Impact to Royalty Revenue Through At Least 2035 Based on Newly Released Draft Medicare Drug Price Negotiation Program Proposed Rule for IPAY 2029 PR Newswire - Mon Jun 15, 5:00AM CDT

SAN DIEGO , June 15, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme" or the "Company") today confirmed that the Company expects zero to minimal royalty revenue impact...

HALO : 79.45 (+3.17%)
HALO
Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today StockStory - Wed Jun 3, 1:35PM CDT

Why Is Halozyme Therapeutics (HALO) Stock Rocketing Higher Today

HALO : 79.45 (+3.17%)
HALO
Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions StockStory - Mon May 18, 12:31AM CDT

Halozyme Therapeutics’s Q1 Earnings Call: Our Top 5 Analyst Questions

HALO : 79.45 (+3.17%)
TOST
3 Growth Stocks Set to Flourish StockStory - Thu May 14, 11:32PM CDT

3 Growth Stocks Set to Flourish

CECO : 82.15 (-3.97%)
TOST : 28.82 (+0.38%)
HALO : 79.45 (+3.17%)
TMO
Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know StockStory - Wed May 13, 12:15PM CDT

Thermo Fisher, Dentsply Sirona, Collegium Pharmaceutical, and Halozyme Therapeutics Stocks Trade Down, What You Need To Know

COLL : 37.03 (+3.23%)
TMO : 523.44 (+1.97%)
XRAY : 11.65 (+5.05%)
HALO : 79.45 (+3.17%)
HALO
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO) StockStory - Tue May 12, 10:34PM CDT

Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)

HALO : 79.45 (+3.17%)
HALO
HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook StockStory - Tue May 12, 12:31AM CDT

HALO Q1 Deep Dive: Royalty Expansion and Pipeline Progress Shape 2026 Outlook

HALO : 79.45 (+3.17%)
MarketBeat.com
Halozyme Therapeutics Q1 Earnings Call Highlights MarketBeat - Mon May 11, 7:09PM CDT

Halozyme Therapeutics (NASDAQ:HALO) reported a sharp increase in first-quarter 2026 revenue and earnings, driven by continued growth in royalties from its ENHANZE drug-delivery platform, and announced...

HALO : 79.45 (+3.17%)

Barchart Exclusives

Applied Materials Stock May Not Be as Expensive as It Seems Even After Record Rally Barchart - 37 minutes ago
Applied Materials' stock has surged to fresh all-time highs after record earnings and a new Street-high $900 price target, highlighting growing confidence in the AI semiconductor equipment cycle. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.